Filing Details

Accession Number:
0001333277-18-000036
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-15 08:08:52
Reporting Period:
2018-05-11
Accepted Time:
2018-05-15 08:08:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1042074 Cymabay Therapeutics Inc. CBAY Pharmaceutical Preparations (2834) 943103561
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588861 Sujal Shah C/O Cymabay Therapeutics, Inc.
7999 Gateway Boulevard
Newark CA 94560
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-11 5,000 $10.65 90,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct